Results of a recent study show that multiple myeloma patients who relapse after pomalidomide therapy may benefit from certain salvage therapies, including Velcade, Revlimid, and stem cell transplantation… “[The study] gives a sense of what therapies still continue to have activity [after patients relapse on pomalidomide],” said Dr. Shaji Kumar of the Mayo Clinic in Rochester, Minnesota, and one of the study authors.
Myeloma Beacon, Howard Chang, 10/18/11
Tags: Cancer